Lymphoma Research Foundation to Honor Leaders in Research, Patient Advocacy and Philanthropy at 2026 Annual Gala
Article excerpt
Dr. Peter Martin, AbbVie and the Werner Family to be recognized at November 13 event in New York City NEW YORK, Nov. 12, 2026 /PRNewswire/ -- The Lymphoma Research Foundation today announced the honorees for its 2026 Annual Gala, taking place Friday, Nov. 13 at the Ziegfeld Ballroom in New York City. The Foundation will honor Dr. Peter Martin, AbbVie and the Werner Family. The gala is the Foundation's largest fundraising event. Last year, the gala raised more than $1.4 million to support its mission to eradicate lymphoma and serve those impacted by the disease. "The progress we have made for people affected by lymphoma and CLL is possible because of the extraordinary commitment of researchers, clinicians, patients, families and partners who believe in our mission," said Meghan Gutierrez, Lymphoma Research Foundation's Chief Executive Officer. "Our gala gives us an opportunity to recognize individuals and organizations whose contributions have strengthened our community, while raising the critical funds that allow us to invest in promising research and provide support to people affected by lymphoma." Dr. Peter Martin, a hematologist-oncologist at NYU Langone Health, will receive the Distinguished Leadership Award for his scientific and clinical leadership in lymphoma care and research, notably his work to advance new treatment approaches and improve outcomes for people with...
Keep reading with a free account
The rest of this article, and every signal for AbbVie, is in your free account.
Extracted from this sentence
AbbVie will receive the Corporate Leadership Award, honoring the company's outstanding commitment to advancing lymphoma research and supporting the lymphoma community through sustained investments in scientific programming and its dedication to expanding patient education and care.
